EPO published patent EP3618889A1 for Fresenius Medical Care covering a blood treatment apparatus with a control unit that executes operating methods. The patent application was filed by Martin Crnkovich and Christian Schlaeper, with IPC classifications including G16H 10/65 (Health informatics for patient data), G16H 20/17 (Health informatics for therapies), and G16H 40/40 and 40/63 (health informatics devices/equipment). The patent is designated for all 31 European states including DE, FR, GB, IT, ES, NL, BE, SE, PL, and others.

Patent holders and competitors in medical device manufacturing and healthcare technology should review this grant to assess freedom-to-operate for similar blood treatment control systems. While no immediate compliance action is required, Fresenius must monitor maintenance fees and consider geographic enforcement strategy. Competitors developing therapeutic apheresis or dialysis equipment with similar control methodologies may need to design around this patent or evaluate licensing options.